• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发病时间窗延长的脑卒中患者的血脑屏障完整性。

Blood-brain barrier integrity of stroke patients presenting in an extended time window.

机构信息

National Institute of Neurological Disorders and Stroke, National Institutes of Health, Building 10, B1D733 MSC 1063, 10 Center Drive, Bethesda, MD, 20892, USA.

出版信息

BMC Neurol. 2020 Feb 13;20(1):54. doi: 10.1186/s12883-020-01634-2.

DOI:10.1186/s12883-020-01634-2
PMID:32054451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7017520/
Abstract

BACKGROUND

Current guidelines limit thrombolytic treatment of stroke to those patients who present within 4.5 h to minimize the risk of hemorrhagic complications. Risk of hemorrhage increases with increasing blood-brain barrier (BBB) disruption. This study aimed to determine, in a cohort of patients presenting outside of an IV-tPA treatment window, whether disruption of the BBB is time dependent, and what proportion of patients could be safely treated.

METHODS

We analyzed untreated stroke patients, seen between 2011 and 2015, who had MRI studies in the time window of 4 to 24 h from symptoms onset. Permeability of the BBB was measured within the ischemic tissue using an application of dynamic susceptibility contrast imaging. Patients were dichotomized into two groups based on a 20% threshold of BBB disruption and compared using logistic regression.

RESULTS

Of the 222 patients included in the final analysis, over half, 129 (58%), had preserved BBB integrity below the 20% threshold. There was no relationship between time imaged after symptom onset and the amount of BBB disruption (p = 0.138) across the population; BBB disruption varied widely.

CONCLUSIONS

Estimating BBB integrity may help to expand the treatment window for stroke patients by identifying those individuals for whom thrombolytic therapy can be considered.

摘要

背景

目前的指南将溶栓治疗中风的时间限制在发病后 4.5 小时内,以最大程度地降低出血并发症的风险。出血风险随着血脑屏障(BBB)破坏的增加而增加。本研究旨在确定在超出 IV-tPA 治疗窗口的患者队列中,BBB 的破坏是否具有时间依赖性,以及有多少患者可以安全治疗。

方法

我们分析了在症状发作后 4 至 24 小时的 MRI 研究时间窗内就诊的未经治疗的中风患者。使用动态对比敏感性成像来测量缺血组织内 BBB 的通透性。根据 BBB 破坏程度达到 20%的阈值将患者分为两组,并使用逻辑回归进行比较。

结果

在最终分析的 222 名患者中,超过一半,129 名(58%)患者的 BBB 完整性保持在 20%阈值以下。在整个患者群体中,成像时间与 BBB 破坏的程度之间没有关系(p=0.138);BBB 的破坏程度差异很大。

结论

估计 BBB 的完整性可能有助于通过识别那些可以考虑溶栓治疗的个体来扩大中风患者的治疗窗口。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b660/7017520/6d9cc82a9791/12883_2020_1634_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b660/7017520/376387342fc3/12883_2020_1634_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b660/7017520/370fc5d1e391/12883_2020_1634_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b660/7017520/3cf288e14dd4/12883_2020_1634_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b660/7017520/6d9cc82a9791/12883_2020_1634_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b660/7017520/376387342fc3/12883_2020_1634_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b660/7017520/370fc5d1e391/12883_2020_1634_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b660/7017520/3cf288e14dd4/12883_2020_1634_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b660/7017520/6d9cc82a9791/12883_2020_1634_Fig4_HTML.jpg

相似文献

1
Blood-brain barrier integrity of stroke patients presenting in an extended time window.发病时间窗延长的脑卒中患者的血脑屏障完整性。
BMC Neurol. 2020 Feb 13;20(1):54. doi: 10.1186/s12883-020-01634-2.
2
Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.急性缺血后人类血脑屏障可逆性破坏的鉴定
Stroke. 2016 Sep;47(9):2405-8. doi: 10.1161/STROKEAHA.116.013805. Epub 2016 Jul 26.
3
Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.常压高氧可减缓血脑屏障损伤,并扩大组织型纤溶酶原激活剂治疗脑缺血的治疗时间窗。
Stroke. 2015 May;46(5):1344-1351. doi: 10.1161/STROKEAHA.114.008599. Epub 2015 Mar 24.
4
Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.经典 Wnt 信号通路在缺血性脑卒中后维持血脑屏障完整性,其激活可改善组织型纤溶酶原激活剂治疗效果。
Mol Neurobiol. 2019 Sep;56(9):6521-6538. doi: 10.1007/s12035-019-1539-9. Epub 2019 Mar 9.
5
MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat.大鼠中使用组织型纤溶酶原激活剂(tPA)辅助AcSDKP治疗中风后血脑屏障破坏的MRI评估
Neuroscience. 2014 Jun 20;271:1-8. doi: 10.1016/j.neuroscience.2014.04.025. Epub 2014 Apr 24.
6
Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.组织型纤溶酶原激活剂给药时间对短暂性脑缺血性中风大鼠血脑屏障通透性及出血性转化的影响
J Neurol Sci. 2014 Dec 15;347(1-2):148-54. doi: 10.1016/j.jns.2014.09.036. Epub 2014 Sep 28.
7
Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.乔松素通过保护血脑屏障功能为组织型纤溶酶原激活物治疗扩展治疗时间窗,改善大鼠血栓性脑卒中模型的预后。
Biomed Res Int. 2018 Apr 22;2018:8943210. doi: 10.1155/2018/8943210. eCollection 2018.
8
Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.短暂性脑低温可减轻延迟性组织型纤溶酶原激活剂再灌注损伤,并延长其在局灶性栓塞性卒中模型中的治疗时间窗。
Brain Res Bull. 2017 Sep;134:85-90. doi: 10.1016/j.brainresbull.2017.07.007. Epub 2017 Jul 11.
9
Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models.间充质干细胞衍生的细胞外囊泡可减轻小鼠缺血性中风模型中组织型纤溶酶原激活剂诱导的血脑屏障破坏。
Acta Biomater. 2022 Dec;154:424-442. doi: 10.1016/j.actbio.2022.10.022. Epub 2022 Oct 29.
10
Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?急性脑梗死患者既往有颅内出血者是否应排除静脉溶栓治疗?
Int J Stroke. 2016 Oct;11(7):783-90. doi: 10.1177/1747493016654289. Epub 2016 Jun 16.

引用本文的文献

1
Factors Associated with Functional Outcome Following Acute Ischemic Stroke Due to M1 MCA/ICA Occlusion in the Extended Time Window.在延长时间窗内,与大脑中动脉M1段/颈内动脉闭塞所致急性缺血性卒中后功能结局相关的因素
J Clin Med. 2025 Aug 6;14(15):5556. doi: 10.3390/jcm14155556.
2
Leucine Reduced Blood-Brain Barrier Disruption and Infarct Size in Early Cerebral Ischemia-Reperfusion.亮氨酸可减轻早期脑缺血再灌注时血脑屏障的破坏及梗死灶大小。
Brain Sci. 2023 Sep 26;13(10):1372. doi: 10.3390/brainsci13101372.
3
Nanotechnology in Stroke: New Trails with Smaller Scales.

本文引用的文献

1
Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.将溶栓时间延长至 4.5-9 小时并用灌注成像进行唤醒性卒中治疗:一项个体患者数据的系统评价和荟萃分析。
Lancet. 2019 Jul 13;394(10193):139-147. doi: 10.1016/S0140-6736(19)31053-0. Epub 2019 May 22.
2
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke.发病 9 小时内采用灌注成像指导的溶栓治疗。
N Engl J Med. 2019 May 9;380(19):1795-1803. doi: 10.1056/NEJMoa1813046.
3
Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection.
纳米技术在中风治疗中的应用:更小尺度的新路径。
Biomedicines. 2023 Mar 4;11(3):780. doi: 10.3390/biomedicines11030780.
4
A Presurgical Unfavorable Prediction Scale of Endovascular Treatment for Acute Ischemic Stroke.急性缺血性卒中血管内治疗的术前不良预测量表
Front Aging Neurosci. 2022 Jun 30;14:942285. doi: 10.3389/fnagi.2022.942285. eCollection 2022.
5
The ATX-LPA Axis Regulates Vascular Permeability during Cerebral Ischemic-Reperfusion.ATX-LPA 轴在脑缺血再灌注期间调节血管通透性。
Int J Mol Sci. 2022 Apr 8;23(8):4138. doi: 10.3390/ijms23084138.
6
Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood-Brain Barrier?脑卒中的细胞治疗:经动脉移植的间充质干细胞是否能穿越血脑屏障?
Cells. 2021 Nov 3;10(11):2997. doi: 10.3390/cells10112997.
7
Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia-Reperfusion With Increased Blood-Brain Barrier Disruption.Rapalink-1在早期脑缺血再灌注中增加梗死面积并加剧血脑屏障破坏。
Front Physiol. 2021 Jul 20;12:706528. doi: 10.3389/fphys.2021.706528. eCollection 2021.
8
Ischemic-hypoxic preconditioning enhances the mitochondrial function recovery of transplanted olfactory mucosa mesenchymal stem cells via miR-181a signaling in ischemic stroke.缺血缺氧预处理通过 miR-181a 信号增强移植嗅黏膜间充质干细胞在缺血性脑卒中后的线粒体功能恢复。
Aging (Albany NY). 2021 Apr 4;13(8):11234-11256. doi: 10.18632/aging.202807.
9
Blood-Brain Barrier Disruption and Hemorrhagic Transformation in Acute Ischemic Stroke: Systematic Review and Meta-Analysis.急性缺血性卒中的血脑屏障破坏与出血性转化:系统评价与荟萃分析
Front Neurol. 2021 Jan 21;11:594613. doi: 10.3389/fneur.2020.594613. eCollection 2020.
10
The Relationship Between Penumbral Tissue and Blood-Brain Barrier Disruption in Acute Stroke Patients Presenting in an Extended Time Window.延长时间窗内就诊的急性卒中患者半暗带组织与血脑屏障破坏的关系
Front Neurol. 2020 Dec 8;11:582994. doi: 10.3389/fneur.2020.582994. eCollection 2020.
使用基于磁共振成像的患者选择方法,延长急性缺血性脑卒中的静脉溶栓时间窗。
Int J Stroke. 2019 Jul;14(5):483-490. doi: 10.1177/1747493019840938. Epub 2019 Apr 4.
4
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.MRI 引导下的不明时间起病脑卒中溶栓治疗。
N Engl J Med. 2018 Aug 16;379(7):611-622. doi: 10.1056/NEJMoa1804355. Epub 2018 May 16.
5
Intravenous thrombolysis in unwitnessed stroke onset: MR WITNESS trial results.未经见证的卒中发病患者的静脉溶栓治疗:MR WITNESS 试验结果。
Ann Neurol. 2018 May;83(5):980-993. doi: 10.1002/ana.25235. Epub 2018 Apr 27.
6
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.2018 急性缺血性脑卒中患者早期管理指南:美国心脏协会/美国卒中协会医疗保健专业人员指南。
Stroke. 2018 Mar;49(3):e46-e110. doi: 10.1161/STR.0000000000000158. Epub 2018 Jan 24.
7
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.6至16小时卒中的血栓切除术及灌注成像选择
N Engl J Med. 2018 Feb 22;378(8):708-718. doi: 10.1056/NEJMoa1713973. Epub 2018 Jan 24.
8
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.发病后 6 至 24 小时内进行取栓术治疗与缺损和梗死不匹配的脑卒中。
N Engl J Med. 2018 Jan 4;378(1):11-21. doi: 10.1056/NEJMoa1706442. Epub 2017 Nov 11.
9
A Comparison of Relative Time to Peak and Tmax for Mismatch-Based Patient Selection.基于错配的患者选择中相对达峰时间和Tmax的比较。
Front Neurol. 2017 Oct 13;8:539. doi: 10.3389/fneur.2017.00539. eCollection 2017.
10
Multiparametric Magnetic Resonance Imaging for Prediction of Parenchymal Hemorrhage in Acute Ischemic Stroke After Reperfusion Therapy.多参数磁共振成像用于预测再灌注治疗后急性缺血性卒中的实质内出血
Stroke. 2017 Mar;48(3):664-670. doi: 10.1161/STROKEAHA.116.014343. Epub 2017 Jan 30.